Loading
Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.
Benjamin Kasenda is a senior physician in internal medicine and haematology/oncology at Universitätsspital Basel, working within the Tumour Centre with a focus on gastrointestinal tumours and lymphoma. He has co-authored prospective phase 2 trials in the Lancet Haematology evaluating high-dose chemotherapy with autologous stem-cell transplantation for primary CNS lymphoma, including in older patients.
Shares the tags clinician-scientist, lymphoma, haematology.
Shares the tags clinician-scientist, lymphoma, haematology.
Shares the tags clinician-scientist, haematology.
Shares the tags clinician-scientist, haematology.
Shares the tags clinician-scientist, lymphoma.
Shares the tags clinician-scientist, haematology.
Shares the tags clinician-scientist, lymphoma.
Shares the tags clinician-scientist, haematology.